Alessandro Padova
Amministratore Delegato presso Fondazione Ri.MED
Profilo
Alessandro Padova is currently the Chief Executive Officer at Fondazione Ri.MED and also holds a Director position at TES Pharma SRL.
He previously served as the Chairman at Actavia Life Sciences, Inc. from 2016 to 2020.
Prior to that, he was the Senior Director-Strategy & Business Development at IRBM Science Park SpA from 2013 to 2015 and the General Manager at Siena Biotech SpA from 2004 to 2013.
He also held Director positions at Active With Me, Inc. and Exosomics SpA, and Externautics SpA.
Dr. Padova holds a doctorate degree from The University of Exeter and an undergraduate degree from the University of Kent.
Posizioni attive di Alessandro Padova
Società | Posizione | Inizio |
---|---|---|
Fondazione Ri.MED
Fondazione Ri.MED Miscellaneous Commercial ServicesCommercial Services Fondazione Ri.MED leads biomedical and biotechnological research projects. The non-profit company is based in Palermo, Italy. Alessandro Padova has been the CEO of the Italian company since 2015. | Amministratore Delegato | 01/10/2015 |
TES Pharma SRL
TES Pharma SRL Medical SpecialtiesHealth Technology TES Pharma SRL provides vitro diagnostics. The private company is based in Corciano, Italy. The Italian company was founded in 2011 by Roberto Pellicciari. Roberto Pellicciari has been the CEO since 2011. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Alessandro Padova
Società | Posizione | Fine |
---|---|---|
ACTAVIA LIFE SCIENCES, INC. | Presidente | 14/10/2020 |
IRBM Science Park SpA
IRBM Science Park SpA Miscellaneous Commercial ServicesCommercial Services IRBM Science Park SpA engages in researching and developing biomedical products. The company is headquartered in Pomezia, Italy. | Corporate Officer/Principal | 01/09/2015 |
Siena Biotech SpA
Siena Biotech SpA Pharmaceuticals: MajorHealth Technology Siena Biotech SpA develops and discovers drugs. The company was founded in 2000 and is headquartered in Siena, Italy. | Corporate Officer/Principal | 01/03/2013 |
Exosomics SpA
Exosomics SpA Medical SpecialtiesHealth Technology Exosomics SpA is an Italian company that manufactures pre-analytical products to isolate nucleic acids from tumor derived extracellular vesicles. The private company is based in Siena, Italy. The company was founded by Antonio Chiesi. Antonio Chiesi has been the CEO since incorporation. | Direttore/Membro del Consiglio | - |
Externautics SpA
Externautics SpA BiotechnologyHealth Technology Externautics SpA provides biotechnology research and development services. The firms designs and manages platforms that identify and develop novel diagnostic and therapeutic markers for oncology applications. Its technology approach is based on the screening of libraries of polyclonal antibodies and recombinant proteins, generated from the corresponding human gene library of the poorly known membrane and secreted proteins. It focuses on the identification of membrane-exposed or serum circulating proteins whose presence associate to the frequent types of human tumors. The company was founded by Guido Grandi in 2007 and is headquartered in Siena, Italy. | Direttore/Membro del Consiglio | - |
Formazione di Alessandro Padova
The University of Exeter | Doctorate Degree |
University of Kent | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ACTAVIA LIFE SCIENCES, INC. | Health Technology |
Aziende private | 7 |
---|---|
Active With Me, Inc.
Active With Me, Inc. Miscellaneous Commercial ServicesCommercial Services Active With Me, Inc. provides online resources that seamlessly offer travelers unique, highly relevant and user-friendly information on activity-based travel. Its listings will be provided for product and service providers of interest to the activity-based traveler. The company was founded on December 6, 2012 and is headquartered in Sarnia, Canada. | Commercial Services |
Externautics SpA
Externautics SpA BiotechnologyHealth Technology Externautics SpA provides biotechnology research and development services. The firms designs and manages platforms that identify and develop novel diagnostic and therapeutic markers for oncology applications. Its technology approach is based on the screening of libraries of polyclonal antibodies and recombinant proteins, generated from the corresponding human gene library of the poorly known membrane and secreted proteins. It focuses on the identification of membrane-exposed or serum circulating proteins whose presence associate to the frequent types of human tumors. The company was founded by Guido Grandi in 2007 and is headquartered in Siena, Italy. | Health Technology |
Siena Biotech SpA
Siena Biotech SpA Pharmaceuticals: MajorHealth Technology Siena Biotech SpA develops and discovers drugs. The company was founded in 2000 and is headquartered in Siena, Italy. | Health Technology |
IRBM Science Park SpA
IRBM Science Park SpA Miscellaneous Commercial ServicesCommercial Services IRBM Science Park SpA engages in researching and developing biomedical products. The company is headquartered in Pomezia, Italy. | Commercial Services |
TES Pharma SRL
TES Pharma SRL Medical SpecialtiesHealth Technology TES Pharma SRL provides vitro diagnostics. The private company is based in Corciano, Italy. The Italian company was founded in 2011 by Roberto Pellicciari. Roberto Pellicciari has been the CEO since 2011. | Health Technology |
Fondazione Ri.MED
Fondazione Ri.MED Miscellaneous Commercial ServicesCommercial Services Fondazione Ri.MED leads biomedical and biotechnological research projects. The non-profit company is based in Palermo, Italy. Alessandro Padova has been the CEO of the Italian company since 2015. | Commercial Services |
Exosomics SpA
Exosomics SpA Medical SpecialtiesHealth Technology Exosomics SpA is an Italian company that manufactures pre-analytical products to isolate nucleic acids from tumor derived extracellular vesicles. The private company is based in Siena, Italy. The company was founded by Antonio Chiesi. Antonio Chiesi has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Alessandro Padova